Ironwood Pharmaceuticals | IRWD - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
Acadia Pharmaceuticals USD 166.33M 17.95M 2026-06
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Almirall EUR 196.15M 20.22M 2026-06
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amarin USD 126.83M 477K 2025-12
Ardelyx USD 82.84M 10.99M 2026-03
Astellas Pharma JPY 844.8B 83.04B 2026-06
AstraZeneca USD 18.86B 972M 2026-06
Charles River Laboratories USD 711.76M 11.5M 2026-06
Coherus Biosciences USD 18.42M 232.08M 2025-12
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Halozyme Therapeutics USD 453.33M 4.66M 2026-06
Incyte USD 1.13B 73.7M 2026-06
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
Lexicon Pharmaceuticals USD 2.38M 50K 2025-12
MacroGenics USD 10.42M 2.95M 2026-03
Moderna USD 17M 54M 2026-06
Myriad Genetics USD 115.3M 2.7M 2025-12
Pacira USD 132.42M 6.78M 2026-06
PTC Therapeutics USD 219.92M 38.3M 2026-03
Puma Biotechnology USD 28.1M 3.52M 2024-06
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
Takeda JPY 956.14B 79.79B 2026-06
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12